Importance of clinical profiling to determine excess mortality in prolactinomas: insights from a large, registry-based cohort.

Shwaish TZT, Gori D, Sartori C, Guaraldi F

Open source

DOI
10.1007/s11102-026-01739-w
Published
2026 Sep 3
Container
Pituitary
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11102-026-01739-w,
  title = {Importance of clinical profiling to determine excess mortality in prolactinomas: insights from a large, registry-based cohort.},
  author = {Shwaish TZT and Gori D and Sartori C and Guaraldi F},
  year = {2026},
  journal = {Pituitary},
  doi = {10.1007/s11102-026-01739-w},
  url = {https://doi.org/10.1007/s11102-026-01739-w}
}

RIS

TY  - JOUR
TI  - Importance of clinical profiling to determine excess mortality in prolactinomas: insights from a large, registry-based cohort.
AU  - Shwaish TZT
AU  - Gori D
AU  - Sartori C
AU  - Guaraldi F
PY  - 2026
JO  - Pituitary
DO  - 10.1007/s11102-026-01739-w
UR  - https://doi.org/10.1007/s11102-026-01739-w
ER  - 

APA

TZT, S., D, G., C, S., & F, G. (2026). Importance of clinical profiling to determine excess mortality in prolactinomas: insights from a large, registry-based cohort.. Pituitary. https://doi.org/10.1007/s11102-026-01739-w

Source records